ContraVir Pharmaceuticals, Inc. (CTRV) has 5 open-market insider trades by 3 insiders since 2014. The most active filer is James Sapirstein, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James Sapirstein | CEO | — | 3 | $15K | 2018-01-03 |
| John T. Cavan | CFO | — | 1 | $13K | 2018-07-03 |
| John P. Brancaccio | Dir | — | 1 | $7K | 2014-03-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| John T. Cavan | CFO | Buy | $13K | 2017-06-20 |
| James Sapirstein | CEO | Buy | $10K | 2016-02-18 |
| James Sapirstein | CEO | Buy | $1K | 2015-11-30 |
| James Sapirstein | CEO | Buy | $4K | 2015-11-23 |
| John P. Brancaccio | Director | Buy | $7K | 2014-03-04 |
Companies that share insiders with CTRV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.